Table.

Demographics and characteristics of subjects with inflammatory macular edema treated with acetazolamide.

Eye #	Age	M/F	Uveitis dx (years)	Uveitis Diagnosis	Prior edema treat.	Systemic meds	Topical meds	Study interval (days)	VA 1	VA 2	CST 1	CST 2	Change CST (um)	(%)	Side Effects
BILATERAL
1R	52	F	7.1	Idiopathic intermediate	none	none	none	35.0	20/25	20/30	400	370	30	8	C, DI, F, N
1L					PA, K, STTA		K QID, PA QID		20/80	20/60	498	353	145	29
2R	63	M	0.3	Idiopathic intermediate	D, Pred	Pred 10 mg	D BID	20.0	20/40	20/30	455	440	15	3*	DI, DY, HL
2L					D, Pred		D BID		20/40	20/30	488	431	57	12*
3R	70	F	0.2	Pseudophakic macular edema	PA, D, K	none	none	55.0	20/32	20/30	393	386	7	2	DE, ED, HY, MA
3L					PA, D, K		none		20/70	20/30	499	408	91	18
UNILATERAL
7R	24	M	0.9	HLA-B27 AU	PA	Pred 20 mg	D QID, N TID	14.0	20/50	20/20	767	362	405	53	none
8L	67	M	10.5	Idiopathic AU	D, N	none	D QID, N TID	30.0	20/50	20/30	585	341	244	42	none
9R	61	F	3.0	Anterior and posterior scleritis	D, N, Pred	MTX 15 mg, Pred 20 mg	D 6× a day, N TID	39.0	20/125	20/60	595	376	219	37	IA, PR
10L	20	M	1.4	DUSN	STTA	none	none	21.0	20/32	20/25	583	374	209	36	DY, PR
11R	68	F	3.1	Prior ARN	N, PA, IB, PPV/MP	MTX 25 mg	D QID	30.0	20/50	20/50	471	310	161	34	DI, G, PR
12R	72	F	1.8	Chronic AU	D, K	none	PA TID	28.0	20/50	20/30	399	251	148	37	PR
13L	38	F	27.5	JIA associated AU	PA	none	PA BID	28.0	20/125	20/40	449	318	131	29	DY, ML, PR
14L	79	M	1.4	Pseudophakic macular edema	PA, IVTA, IB	none	none	43.0	20/100	20/100	573	444	129	23	C, F, DY, PR
15R	65	F	2.4	Birdshot choroiditis	PA, D, K, N, STTA, Pred	MTX 15mg, Pred 20mg,	D QID, N TID	28.0	20/40	20/40	390	337	53	14	F, DI, DY, PR
16L	58	F	4.1	HLA-B27 AU	D, N, STTA, IVTA,	Humira 40mg Q 2 wk	D QID, N QID	35.0	20/40	20/30	341	305	36	11*	F, DY, PO, PR
17L	52	M	5.8	Sarcoidosis	PA, D, STTA, Pred, PPV/MP	MTX 25mg, AZA 100 mg, Pred 10 mg	D QID,	38.0	20/40	20/30	385	357	28	7	none
18L	81	M	2.5	Pseudophakic macular edema	PA	none	PA BID,	42.0	20/40	20/40	327	302	25	8*	PR
19L	46	F	3.7	Demyelination associated	D, N	none	D TID, N BID	21.0	20/50	20/50	366	342	24	7	F, PR

^*Complete resolution of macular edema

Abbreviations:

Treatment/Medications	Diagnosis	Side effects	Other
PA= 1% Prednisolone acetate D= 0.5% Difluprednate Pred= Oral prednisone N= 0.1 % Nepafenac K= 0.5% Ketorolac STTA= Subtenons triamcinolone IB= Intravitreal bevacizumab IVTA= Intravitreal triamcinolone AZA= Azathioprine MTX= Methotrexate PPV/MP= Pars plana vitrectomy with internal limiting membrane peel BID= Twice a day TID= Three times a day QID= Four times a day	ARN= Acute retinal necrosis AU= Anterior Uveitis DUSN= Diffuse unilateral subacute neuroretinitis HLAB27= human leukocyte antigen B27 JIA= Juvenile Idiopathic Arthritis associated	C= Confusion/Disorientation DE= Dehydration DI= Diarrhea DY= Dysguesia ED= Emergency visit F= Fatigue G= Gastroesophageal reflux HL= Hearing Loss HY= Hypotension IA= Increased Appetite MA= Malaise ML= Memory Loss N= Nausea PO= Polydipsia PR= Paresthesia	CST= Central subfield thickness VA= Visual acuity CAI= Carbonic anhydrase inhibitor SE= Side effect D/C= Discontinuation IC= Insurance Coverage